The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
In the latest session, Alkermes plc (NASDAQ: ALKS) closed at $33.92 down -1.22% from its previous closing price of $34.34. In other words, the price has decreased by -$1.22 from its previous closing price. On the day, 1.27 million shares were traded. ALKS stock price reached its highest trading level at $34.465 during the session, while it also had its lowest trading level at $33.72.
Ratios:
For a deeper understanding of Alkermes plc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.34 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 13.60. For the most recent quarter (mrq), Quick Ratio is recorded 2.65 and its Current Ratio is at 3.04. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, RBC Capital Mkts on March 13, 2025, initiated with a Sector Perform rating and assigned the stock a target price of $40.
On March 04, 2025, UBS Upgraded its rating to Neutral which previously was Sell and also upped its target price recommendation from $21 to $38.
On February 11, 2025, Deutsche Bank started tracking the stock assigning a Buy rating and target price of $40.Deutsche Bank initiated its Buy rating on February 11, 2025, with a $40 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Feb 28 ’25 when Parisi Samuel Joseph sold 1,938 shares for $34.00 per share. The transaction valued at 65,892 led to the insider holds 7,717 shares of the business.
Parisi Samuel Joseph sold 3,743 shares of ALKS for $131,978 on Feb 25 ’25. The VP, Finance (Interim PAO) now owns 7,717 shares after completing the transaction at $35.26 per share. On Feb 20 ’25, another insider, Parisi Samuel Joseph, who serves as the VP, Finance (Interim PAO) of the company, sold 1,327 shares for $35.69 each. As a result, the insider received 47,361 and left with 7,717 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALKS now has a Market Capitalization of 5515866624 and an Enterprise Value of 4839739392. As of this moment, Alkermes’s Price-to-Earnings (P/E) ratio for their current fiscal year is 15.56, and their Forward P/E ratio for the next fiscal year is 18.16. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.54 while its Price-to-Book (P/B) ratio in mrq is 3.76. Its current Enterprise Value per Revenue stands at 3.107 whereas that against EBITDA is 10.775.
Stock Price History:
The Beta on a monthly basis for ALKS is 0.37, which has changed by 0.24294615 over the last 52 weeks, in comparison to a change of 0.08190584 over the same period for the S&P500. Over the past 52 weeks, ALKS has reached a high of $36.45, while it has fallen to a 52-week low of $22.90. The 50-Day Moving Average of the stock is 3.81%, while the 200-Day Moving Average is calculated to be 18.38%.
Shares Statistics:
For the past three months, ALKS has traded an average of 1.66M shares per day and 1622240 over the past ten days. A total of 162.18M shares are outstanding, with a floating share count of 158.43M. Insiders hold about 2.57% of the company’s shares, while institutions hold 102.81% stake in the company. Shares short for ALKS as of 1740700800 were 14008923 with a Short Ratio of 8.44, compared to 1738281600 on 10824850. Therefore, it implies a Short% of Shares Outstanding of 14008923 and a Short% of Float of 12.83.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The firm’s stock currently is rated by 11.0 analysts. The consensus estimate for the next quarter is $0.48, with high estimates of $0.56 and low estimates of $0.39.
Analysts are recommending an EPS of between $2.17 and $1.57 for the fiscal current year, implying an average EPS of $1.85. EPS for the following year is $1.85, with 13.0 analysts recommending between $2.2 and $1.43.
Revenue Estimates
A total of 13 analysts believe the company’s revenue will be $309.08M this quarter.It ranges from a high estimate of $340.99M to a low estimate of $292M. As of the current estimate, Alkermes plc’s year-ago sales were $350.37MFor the next quarter, 13 analysts are estimating revenue of $347.06M. There is a high estimate of $358.34M for the next quarter, whereas the lowest estimate is $335.7M.
A total of 15 analysts have provided revenue estimates for ALKS’s current fiscal year. The highest revenue estimate was $1.42B, while the lowest revenue estimate was $1.37B, resulting in an average revenue estimate of $1.39B. In the same quarter a year ago, actual revenue was $1.56BBased on 16 analysts’ estimates, the company’s revenue will be $1.45B in the next fiscal year. The high estimate is $1.59B and the low estimate is $1.35B.
